THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM PHILADELPHIA, PA / ACCESS Newswire / ...

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire ...

Lipocine ( ($LPCN) ) has shared an update. On November 18, 2025, Lipocine announced promising interim safety results from its Phase 3 clinical ...

Once E3 tags CYP17A1, the cell uses its proteasome to break down the enzyme entirely. One major advantage of PROTACs is that ...

Discover the critical signs of low testosterone that men over 40 should not ignore. Learn how these symptoms can impact your ...

Gut, immune, and hormone disruptions reveal why long COVID symptoms can be more intense and long lasting in many women.

This article was reviewed by Darragh O’Carroll, MD. Once You Start Testosterone Therapy, Can You Stop? Key Takeaways: Spoiler ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...

A decade ago, Cindy Eckert struggled to convince skeptics about a drug for premenopausal women. Lately, her business is ...

The violations were related to opioid prescription management, and disciplinary actions taken in other states. In April, ...

Many men start noticing changes in their 30s, 40s or 50s—feeling more tired, less motivated and not quite themselves. It’s ...

On November 10, the Food and Drug Administration announced it will remove the black box warning applied to estrogen-containing products since 2002. As the head of the FDA declared, “After 23 years of ...